Andelyn Biosciences
Columbus
About Andelyn Biosciences
Andelyn Biosciences is a biopharmaceutical company that delivers treatments and therapies for patients. They provide preclinical research and development, Viral Vector process and analytical development, small to large-scale GMP manufacturing up to 2000L, Fill/Finish, and quality release testing to their clients. Plasmid manufacturing services are available at the research, toxicology, and Phase I/IIa GMP levels for vertical integration, accelerated timelines, and optimized production yields. Its edge technologies help to advance the field of gene and cell-based therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $5.0M
- Last round: Grant (Feb 2022)
- Website: andelynbio.com
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Manufacturing, Product Research
Social Profiles
Canonical: https://fsome.com/organization/andelyn-biosciences-76806 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.